Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VX-809 Monotherapy in CF (F508del Homozygous)
NCT00865904Phase 2Completed
- Sponsor
- Vertex Pharmaceuticals
- Start
- Mar 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of lumacaftor in cystic fibrosis (CF), sponsored by Vertex Pharmaceuticals. Started Mar 2009; status: completed.
02
Drugs
lumacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00865904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00865904.